Itau Unibanco Holding S.A. Bridge Bio Pharma, Inc. Transaction History

Itau Unibanco Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $3,519 - $4,749	153 New	153 $3,000
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $6,245 - $11,411	260 New	260 $10,000
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $86 - $222	-12 Reduced 0.56%	2,144 $35,000
Q4 2022 Feb 09, 2023	SELL	$6.74 - $11.52 $4,407 - $7,534	-654 Reduced 23.27%	2,156 $16,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $22,311 - $34,731	2,810 New	2,810 $28,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $1,057 - $2,464	-203 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $204 - $961	18 Added 9.73%	203 $3,000
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $234 - $321	5 Added 2.78%	185 $9,000
Q2 2021 Aug 17, 2021	BUY	$46.47 - $63.93 $8,364 - $11,507	180 New	180 $11,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.